EMEA-000966-PIP01-10 - paediatric investigation plan

aqueous allergen extract of pollen from Phleum pratense

Key facts

• Active substance:
  aqueous allergen extract of pollen from Phleum pratense
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/335/2010
• PIP number:
  EMEA-000966-PIP01-10
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Sublingual use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  22/12/2010
• Compliance check done:
  No

Decision

P/335/2010: EMA decision of 22 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for aqueous allergen extract of pollen from phleum prate...

Adopted Reference Number: EMA/810422/2010